Physician profile
Jones M Gresham
NPI 1326026618
$1,546.11
in general payments reported to CMS, 2019-2025
21 companies · $285 in 2025
The $285 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $245 · 2020: $140 · 2021: $223 · 2022: $400 · 2023: $121 · 2024: $132 · 2025: $285.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $438 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $438.25 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $581.08 | 2019-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $295.30 | 2019-2023 | |
| Channel Medsystems, INC. | $162.89 | 2022-2024 | |
| Exeltis, USA INC. | $64.94 | 2020-2021 | |
| Hologic Sales and Service, LLC | $50.78 | 2020-2021 | |
| Caldera Medical, INC | $46.56 | 2021 | |
| Coopersurgical, INC. | $41.52 | 2019-2020 | |
| Evofem Biosciences, INC. | $37.50 | 2021-2022 | |
| Organon LLC | $35.77 | 2022-2023 | Nexplanon |
| Intuitive Surgical, INC. | $29.51 | 2023 | Da Vinci Surgical System |
| Allergan, INC. | $28.58 | 2019 | |
| Novo Nordisk INC | $24.76 | 2020 | |
| Mylan Pharmaceuticals INC. | $24.37 | 2022 | |
| Biogen, INC. | $21.01 | 2024 | |
| Sumitomo Pharma America, INC. | $18.98 | 2025 | Gemtesa |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $17.57 | 2021 | |
| Axonics, INC. | $15.56 | 2021 | |
| Minerva Surgical, INC | $13.86 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.37 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $11.15 | 2019 | |
| Ethicon US, LLC | $11.05 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jones Gresham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.